Effects of ensaculin on dopamine metabolite levels and K(+)-induced glutamate release

Peter Teismann, B Ferger

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

In vivo microdialysis with the new antidementia compound ensaculin was performed in freely moving rats to study the alterations in dopaminergic and glutamatergic neurotransmission. Ensaculin (0.1 and 1 mg/kg i.p.) significantly increased extracellular levels of the dopamine metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). Furthermore, ensaculin (1 mg/kg i.p.) showed a non-significant tendency to reduce the K(+)-induced glutamate release. The data suggest that ensaculin may have moderate D(2) antagonistic properties. Thus, besides its possible role as a cognitive enhancer, ensaculin may also have moderate antipsychotic properties.
Original languageEnglish
Pages (from-to)247-250
Number of pages4
JournalEuropean Journal of Pharmacology
Volume398
Issue number2
Early online date13 Jun 2000
DOIs
Publication statusPublished - 16 Jun 2000

Fingerprint

Glutamic Acid
Dopamine
Nootropic Agents
3,4-Dihydroxyphenylacetic Acid
Homovanillic Acid
Microdialysis
Synaptic Transmission
Antipsychotic Agents
Ensaculin

Keywords

  • 3,4-Dihydroxyphenylacetic Acid
  • Animals
  • Benzopyrans
  • Chromatography, High Pressure Liquid
  • Corpus Striatum
  • Dopamine
  • Glutamic Acid
  • Homovanillic Acid
  • Male
  • Microdialysis
  • Piperazines
  • Potassium
  • Rats
  • Rats, Wistar
  • Ensaculin
  • Dopamine
  • DOPAC (3,4-dihydroxyphenylacetic acid)
  • Glutamate
  • Rat

Cite this

Effects of ensaculin on dopamine metabolite levels and K(+)-induced glutamate release. / Teismann, Peter; Ferger, B.

In: European Journal of Pharmacology, Vol. 398, No. 2, 16.06.2000, p. 247-250.

Research output: Contribution to journalArticle

@article{40bc0aadf6ac4a7ea26e5e24c62db8fb,
title = "Effects of ensaculin on dopamine metabolite levels and K(+)-induced glutamate release",
abstract = "In vivo microdialysis with the new antidementia compound ensaculin was performed in freely moving rats to study the alterations in dopaminergic and glutamatergic neurotransmission. Ensaculin (0.1 and 1 mg/kg i.p.) significantly increased extracellular levels of the dopamine metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). Furthermore, ensaculin (1 mg/kg i.p.) showed a non-significant tendency to reduce the K(+)-induced glutamate release. The data suggest that ensaculin may have moderate D(2) antagonistic properties. Thus, besides its possible role as a cognitive enhancer, ensaculin may also have moderate antipsychotic properties.",
keywords = "3,4-Dihydroxyphenylacetic Acid, Animals, Benzopyrans, Chromatography, High Pressure Liquid, Corpus Striatum, Dopamine, Glutamic Acid, Homovanillic Acid, Male, Microdialysis, Piperazines, Potassium, Rats, Rats, Wistar, Ensaculin, Dopamine, DOPAC (3,4-dihydroxyphenylacetic acid) , Glutamate, Rat",
author = "Peter Teismann and B Ferger",
year = "2000",
month = "6",
day = "16",
doi = "10.1016/S0014-2999(00)00290-9",
language = "English",
volume = "398",
pages = "247--250",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Effects of ensaculin on dopamine metabolite levels and K(+)-induced glutamate release

AU - Teismann, Peter

AU - Ferger, B

PY - 2000/6/16

Y1 - 2000/6/16

N2 - In vivo microdialysis with the new antidementia compound ensaculin was performed in freely moving rats to study the alterations in dopaminergic and glutamatergic neurotransmission. Ensaculin (0.1 and 1 mg/kg i.p.) significantly increased extracellular levels of the dopamine metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). Furthermore, ensaculin (1 mg/kg i.p.) showed a non-significant tendency to reduce the K(+)-induced glutamate release. The data suggest that ensaculin may have moderate D(2) antagonistic properties. Thus, besides its possible role as a cognitive enhancer, ensaculin may also have moderate antipsychotic properties.

AB - In vivo microdialysis with the new antidementia compound ensaculin was performed in freely moving rats to study the alterations in dopaminergic and glutamatergic neurotransmission. Ensaculin (0.1 and 1 mg/kg i.p.) significantly increased extracellular levels of the dopamine metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA). Furthermore, ensaculin (1 mg/kg i.p.) showed a non-significant tendency to reduce the K(+)-induced glutamate release. The data suggest that ensaculin may have moderate D(2) antagonistic properties. Thus, besides its possible role as a cognitive enhancer, ensaculin may also have moderate antipsychotic properties.

KW - 3,4-Dihydroxyphenylacetic Acid

KW - Animals

KW - Benzopyrans

KW - Chromatography, High Pressure Liquid

KW - Corpus Striatum

KW - Dopamine

KW - Glutamic Acid

KW - Homovanillic Acid

KW - Male

KW - Microdialysis

KW - Piperazines

KW - Potassium

KW - Rats

KW - Rats, Wistar

KW - Ensaculin

KW - Dopamine

KW - DOPAC (3,4-dihydroxyphenylacetic acid)

KW - Glutamate

KW - Rat

U2 - 10.1016/S0014-2999(00)00290-9

DO - 10.1016/S0014-2999(00)00290-9

M3 - Article

C2 - 10854836

VL - 398

SP - 247

EP - 250

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2

ER -